General Information of MET (ID: META00266)
Name ATP
Synonyms   Click to Show/Hide Synonyms of This Metabolite
ATP MGCL2; ATP', Adenosine 5'-triphosphoric acid, ADENOSINE-5'-triphosphoric acid, 'Adenosine triphosphoric acid', 5'-(Tetrahydrogen triphosphate) adenosine, 5'-ATP, Adenosine 5'-triphosphorate, 'Adenylpyrophosphorate; ATP-MGCL2; Adenosine 5'-triphosphate, ADENOSINE-5'-triphosphATE, 'Adephos; Adenosine triphosphate, calcium salt; Adenosine triphosphate, chromium ammonium salt; Adenosine triphosphate, chromium salt; Adenosine triphosphate, magnesium chloride; Adenosine triphosphate, magnesium salt; Adenosine triphosphate, manganese salt; Adenylpyrophosphate; Adenylpyrophosphoric acid; Adetol; Adynol; Atipi; Atriphos; CR(H2O)4 ATP; CaATP; Cardenosine; Chromium adenosine triphosphate; CrATP; Fosfobion; Glucobasin; H4ATP; Magnesium adenosine triphosphate; Manganese adenosine triphosphate; MgATP; MnATP; Myotriphos; Phosphobion; Striadyne; Triadenyl; Triphosphaden; Triphosphoric acid adenosine ester
Source Endogenous;Escherichia Coli Metabolite;Yeast Metabolite;Food;Drug;Toxins/Pollutant;Cosmetic;Microbial
Structure Type   Purine ribonucleotides  (Click to Show/Hide the Complete Structure Type Hierarchy)
Nucleosides, nucleotides, and analogues
Purine nucleotides
Purine ribonucleotides
PubChem CID
5957
HMDB ID
HMDB0000538
Formula
C10H16N5O13P3
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5957"></iframe>
3D MOL 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
KEGG ID
C00002
DrugBank ID
DB00171
ChEBI ID
15422
FooDB ID
FDB030683
ChemSpider ID
5742
METLIN ID
5523
Physicochemical Properties Molecular Weight 507.18 Topological Polar Surface Area 279
XlogP -5.7 Complexity 800
Heavy Atom Count 31 Rotatable Bond Count 8
Hydrogen Bond Donor Count 7 Hydrogen Bond Acceptor Count 17
Function
Adenosine triphosphate (ATP) is a nucleotide consisting of a purine base (adenine) attached to the first carbon atom of ribose (a pentose sugar). Three phosphate groups are esterified at the fifth carbon atom of the ribose. ATP is incorporated into nucleic acids by polymerases in the processes of DNA replication and transcription. ATP contributes to cellular energy charge and participates in overall energy balance, maintaining cellular homeostasis. ATP can act as an extracellular signaling molecule via interactions with specific purinergic receptors to mediate a wide variety of processes as diverse as neurotransmission, inflammation, apoptosis, and bone remodelling. Extracellular ATP and its metabolite adenosine have also been shown to exert a variety of effects on nearly every cell type in human skin, and ATP seems to play a direct role in triggering skin inflammatory, regenerative, and fibrotic responses to mechanical injury, an indirect role in melanocyte proliferation and apoptosis, and a complex role in Langerhans cell-directed adaptive immunity. During exercise, intracellular homeostasis depends on the matching of adenosine triphosphate (ATP) supply and ATP demand. Metabolites play a useful role in communicating the extent of ATP demand to the metabolic supply pathways. Effects as different as proliferation or differentiation, chemotaxis, release of cytokines or lysosomal constituents, and generation of reactive oxygen or nitrogen species are elicited upon stimulation of blood cells with extracellular ATP. The increased concentration of adenosine triphosphate (ATP) in erythrocytes from patients with chronic renal failure (CRF) has been observed in many studies but the mechanism leading to these abnormalities still is controversial.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      GPCR rhodopsin (GPCR-1)
            Orexin receptor type 1 (HCRTR1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Inhibition (SB334867) of HCRTR1
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Hepatocellular carcinoma [ICD-11: 2C12]
                      Details It is reported that inhibition of HCRTR1 leads to the decrease of ATP levels compared with control group.
      Hydrolases (EC 3)
            Extracellular sulfatase Sulf-1 (SULF1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockout of Sulf1
                      Induced Change ATP concentration: increase (FC = 1.37)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Ovarian cancer [ICD-11: 2C73]
                      Details It is reported that knockout of Sulf1 leads to the increase of ATP levels compared with control group.
            Phosphoinositide lipid phosphatase (PLIP) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [3]
                      Introduced Variation Knockout of Ptpmt1
                      Induced Change ATP concentration: decrease (FC= 0.50)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockout of Ptpmt1 leads to the decrease of ATP levels compared with control group.
            Sulfatase sulf-1 (SULF1) Click to Show/Hide the Full List of Regulating Pair(s):   2 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair (1) Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockdown (shRNA) of SULF1
                      Induced Change ATP concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Ovarian cancer [ICD-11: 2C73]
                      Details It is reported that knockdown of SULF1 leads to the increase of ATP levels compared with control group.
               Regulating Pair (2) Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Overexpression of SULF1
                      Induced Change ATP concentration: decrease (FC = 0.50)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Ovarian cancer [ICD-11: 2C73]
                      Details It is reported that overexpression of SULF1 leads to the decrease of ATP levels compared with control group.
      Ligases (EC 6)
            Methylcrotonoyl-CoA carboxylase alpha (MCCC1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [4]
                      Introduced Variation Mutation ( c.1263dupG, p.Q421AfsX10; c.1263dupG/c.1682-3A>G, p.Q421AfsX10/p.N561KfsX10) of MCCC1
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Lipid metabolism disorders [ICD-11: 5C52]
                      Details It is reported that mutation ( c.1263dupG, p.Q421AfsX10; c.1263dupG/c.1682-3A>G, p.Q421AfsX10/p.N561KfsX10) of MCCC1 leads to the decrease of ATP levels compared with control group.
      Mitochondrial carrier (MC)
            Oxoglutarate/malate carrier protein (SLC25A11) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [5]
                      Introduced Variation Knockdown (siRNA) of SLC25A11
                      Induced Change ATP concentration: decrease (FC = 0.25)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Melanoma [ICD-11: 2C30]
                      Details It is reported that knockdown of SLC25A11 leads to the decrease of ATP levels compared with control group.
      Oxidoreductases (EC 1)
            Formyltetrahydrofolate dehydrogenase (ALDH1L2) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [6]
                      Introduced Variation Mutation of ALDH1L2
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Genetic disorders of keratinisation [ICD-11: EC20]
                      Details It is reported that mutation (patients) of ALDH1L2 leads to the decrease of ATP levels compared with control group.
            Glucose-6-phosphate dehydrogenase (G6PD) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [7]
                      Introduced Variation Knockdown (siRNA) of G6PD
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockdown of G6PD leads to the decrease of ATP levels compared with control group.
            Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [7]
                      Introduced Variation Knockdown (siRNA) of Gapdh
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockdown of Gapdh leads to the decrease of ATP levels compared with control group.
      Sodium/anion cotransporter (SAC)
            Solute carrier family 17 member 9 (SLC17A9) Click to Show/Hide the Full List of Regulating Pair(s):   4 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair (1) Experim Info click to show the details of experiment for validating this pair [8]
                      Introduced Variation Knockdown (siRNA) of Slc17a9
                      Induced Change ATP concentration: decrease (FC = 0.50)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Adrenomedullary hyperfunction [ICD-11: 5A75]
                      Details It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group.
               Regulating Pair (2) Experim Info click to show the details of experiment for validating this pair [8]
                      Introduced Variation Knockdown (siRNA) of SLC17A9
                      Induced Change ATP concentration: decrease (FC = 0.50)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Adrenomedullary hyperfunction [ICD-11: 5A75]
                      Details It is reported that knockdown of SLC17A9 leads to the decrease of ATP levels compared with control group.
               Regulating Pair (3) Experim Info click to show the details of experiment for validating this pair [9]
                      Introduced Variation Knockdown (shRNA) of Slc17a9
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group.
               Regulating Pair (4) Experim Info click to show the details of experiment for validating this pair [9]
                      Introduced Variation Overexpression of Slc17a9
                      Induced Change ATP concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that overexpression of Slc17a9 leads to the increase of ATP levels compared with control group.
      Sugar transporter (ST)
            Facilitated glucose transporter 1 (SLC2A1A) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [10]
                      Introduced Variation Downregulation of slc2a1a caused by Yap loss-of-function mutation
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that downregulation of slc2a1a caused by Yap loss-of-function mutation leads to the decrease of ATP levels compared with control group.
      Transcription factor (TF)
            Hypoxia-inducible factor 1-alpha (HIF1A) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Inhibition (YC-1) of HIF1A
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Hepatocellular carcinoma [ICD-11: 2C12]
                      Details It is reported that inhibition of HIF1A leads to the decrease of ATP levels compared with control group.
      Transcriptional coactivator (TC)
            Transcriptional coactivator YAP1 (yap1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [10]
                      Introduced Variation Decrease of Yap mRNA caused by Yap loss-of-function mutation
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that decrease of Yap mRNA caused by Yap loss-of-function mutation leads to the decrease of ATP levels compared with control group.
      Transferases (EC 2)
            6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) Click to Show/Hide the Full List of Regulating Pair(s):   3 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair (1) Experim Info click to show the details of experiment for validating this pair [11]
                      Introduced Variation Knockdown (shRNA) of PFKFB4
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Breast cancer [ICD-11: 2C60] ...
                      Details It is reported that knockdown of PFKFB4 leads to the decrease of ATP levels compared with control group.
               Regulating Pair (2) Experim Info click to show the details of experiment for validating this pair [11]
                      Introduced Variation Overexpression of PFKFB4
                      Induced Change ATP concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Breast cancer [ICD-11: 2C60] ...
                      Details It is reported that overexpression of PFKFB4 leads to the increase of ATP levels compared with control group.
               Regulating Pair (3) Experim Info click to show the details of experiment for validating this pair [11]
                      Introduced Variation Knockdown (shRNA) of Pfkfb4
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Lung cancer [ICD-11: 2C25]
                      Details It is reported that knockdown of Pfkfb4 leads to the decrease of ATP levels compared with control group.
            Isoprenylcysteine carboxylmethyltransferase (ICMT) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [12]
                      Introduced Variation Inhibition (Cysmethynil) of ICMT
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Prostate cancer [ICD-11: 2C82]
                      Details It is reported that inhibition of ICMT leads to the decrease of ATP levels compared with control group.
            Pyridoxal kinase (PDXK) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [13]
                      Introduced Variation Knockout (CRISPR/Cas9 sgRNA) of Pdxk
                      Induced Change ATP concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Acute myeloid leukaemia [ICD-11: 2A60]
                      Details It is reported that knockout of Pdxk leads to the decrease of ATP levels compared with control group.
            Transaldolase (TALDO1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [14]
                      Introduced Variation Knockout of Taldo1
                      Induced Change ATP concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockout of Taldo1 leads to the increase of ATP levels compared with control group.
            Transketolase-like protein 1 (TKTL1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [15]
                      Introduced Variation Overexpression of TKTL1
                      Induced Change ATP concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Head and neck squamous cell carcinoma [ICD-11: 2D60]
                      Details It is reported that overexpression of TKTL1 leads to the increase of ATP levels compared with control group.
References
1 Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1-dependent and -independent mechanism. PLoS One. 2017 Sep 8;12(9):e0184213.
2 HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget. 2015 Oct 20;6(32):33705-19.
3 Mitochondrial oxidation of the carbohydrate fuel is required for neural precursor/stem cell function and postnatal cerebellar development. Sci Adv. 2018 Oct 10;4(10):eaat2681.
4 A 3-methylcrotonyl-CoA carboxylase deficient human skin fibroblast transcriptome reveals underlying mitochondrial dysfunction and oxidative stress. Int J Biochem Cell Biol. 2016 Sep;78:116-129.
5 Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation. EBioMedicine. 2019 Feb;40:184-197.
6 Deleterious mutations in ALDH1L2 suggest a novel cause for neuro-ichthyotic syndrome. NPJ Genom Med. 2019 Jul 23;4:17.
7 Glucose metabolism during in vitro maturation of mouse oocytes: An study using RNA interference. J Cell Physiol. 2018 Sep;233(9):6952-6964.
8 Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5683-6.
9 SLC17A9 protein functions as a lysosomal ATP transporter and regulates cell viability. J Biol Chem. 2014 Aug 15;289(33):23189-23199.
10 Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J. 2018 Nov 15;37(22):e100294.
11 Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth. Oncotarget. 2014 Aug 30;5(16):6670-86.
12 Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism. Oncogene. 2015 Jun;34(25):3296-304.
13 Vitamin B6 Addiction in Acute Myeloid Leukemia. Cancer Cell. 2020 Jan 13;37(1):71-84.e7.
14 Two isoforms of TALDO1 generated by alternative translational initiation show differential nucleocytoplasmic distribution to regulate the global metabolic network. Sci Rep. 2016 Oct 5;6:34648.
15 TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res. 2010 Feb 1;16(3):857-66.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.